Latest news with #TAP
The Print
a day ago
- Sport
- The Print
Indian junior archers enter three finals at Asia Cup Stage 2
The trio of Vishnu Choudhary, Paras Hooda and Juyel Sarkar dominated from the outset, taking the opening set 55-48. The Indian men's recurve team, seeded second, defeated fifth-seeded Bangladesh 5-1 in a one-sided semifinal to set up a summit clash with third seeds Japan. Singapore, Jun 19 (PTI) Indian junior archers continued their dominating run by storming into three team finals at the Asia Cup Stage 2 here on Thursday. Although the second set was tied at 55-55, the Indians bounced back strongly, dropping just one point in the third set to win it 59-56 and seal the issue. India also assured themselves of a medal in the compound men's team event after the trio of Kushal Dalal, Ganesh Thirumuru and Mihir Apar edged past fifth-seeded Australia in a tense semifinal decided by a shoot-off (30-29) after both teams were tied at 232 after four sets. India will take on Kazakhstan in the final. The top-seeded Indian compound women's team comprising Shanmukhi Budde, Tejal Salve and Tanishka Thokal defeated fourth-seeded Kazakhstan 230-229 in a nail-biting semifinal to ensure another medal. They will meet Malaysia in the final. However, there was heartbreak for the Indian women's recurve team. Seeded fifth, the troika of Vaishnavi Pawar, Kirti, and Tamanna lost a thrilling quarterfinal to fourth seeds Japan 4-5 (26-28) in the shoot-off after a five-set battle. They lost the opening set 47-49 and slumped further after managing only 34 in the second set to Japan's 55. But the Indians showed great resilience to take the third set 55-53 and level the scores 4-4 after claiming the fourth set 54-52. In the shoot-off, Japan edged ahead by just two points. Indian archers are also in the hunt for four individual medals on the concluding day on Friday. The women's compound final will be an all-Indian affair, with Shanmukhi set to face Tejal for gold. In the men's compound section, India will be in the hunt in both the gold and bronze medal matches. Kushal will face Joshua Mahon of Australia for the gold, while Sachin Chechi will take on Himu Bachhar of Bangladesh for bronze. PTI TAP APA APA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Yahoo
3 days ago
- Business
- Yahoo
Gradient Denervation Technologies Announces Acceptance into FDA's Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food and Drug Administration (FDA) for the development of its novel technology intended to treat patients with pulmonary hypertension and associated heart failure. The TAP Pilot acceptance follows the Company's recent announcement that the FDA granted Breakthrough Device Designation for the Gradient Denervation System. The FDA's Center for Devices and Radiological Health (CDRH) launched the TAP Pilot to help expedite patient access to safe and effective, innovative medical devices. To help accelerate development of Gradient's Denervation System, the TAP Pilot will allow the company to have early and frequent interactions with FDA as well as obtain strategic advice from providers, associations, payors and patient organizations. The Gradient Denervation System is a novel technology intended to treat patients with Group 2 pulmonary hypertension due to left-sided heart disease. Treatment is accomplished by ablating nerves around the pulmonary artery using therapeutic ultrasound energy in a minimally invasive, percutaneous procedure. The straightforward catheter platform was designed specifically for the pulmonary artery anatomy and leverages known interventional techniques. The treatment goal is to down-regulate the sympathetic activity in the pulmonary vascular tree to reduce vascular resistance and decrease pulmonary pressures. 'We're excited to be included in the TAP Pilot as the program will help streamline collaboration with FDA – from initiating our pivotal clinical study to accelerating access to this breakthrough therapy upon approval,' said Martin Grasse, Chief Executive Officer at Gradient Denervation Technologies. 'There are no approved drug or device therapies in the United States for this group of pulmonary hypertension patients, which reinforces the need to expedite access to new innovative therapies. We expect that guidance from TAP Pilot advisors will be immensely valuable in developing a targeted therapy intended to improve outcomes and quality of life for these underserved patients.' About Gradient Denervation TechnologiesGradient Denervation Technologies is a Paris-based medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension. Gradient leverages intellectual property developed at Stanford University. The Gradient Denervation System is for investigational use only and is not approved for commercial use. For more information, please visit: CONTACT: Media Contact contact@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Gradient Denervation Technologies Announces Acceptance into FDA's Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food and Drug Administration (FDA) for the development of its novel technology intended to treat patients with pulmonary hypertension and associated heart failure. The TAP Pilot acceptance follows the Company's recent announcement that the FDA granted Breakthrough Device Designation for the Gradient Denervation System. The FDA's Center for Devices and Radiological Health (CDRH) launched the TAP Pilot to help expedite patient access to safe and effective, innovative medical devices. To help accelerate development of Gradient's Denervation System, the TAP Pilot will allow the company to have early and frequent interactions with FDA as well as obtain strategic advice from providers, associations, payors and patient organizations. The Gradient Denervation System is a novel technology intended to treat patients with Group 2 pulmonary hypertension due to left-sided heart disease. Treatment is accomplished by ablating nerves around the pulmonary artery using therapeutic ultrasound energy in a minimally invasive, percutaneous procedure. The straightforward catheter platform was designed specifically for the pulmonary artery anatomy and leverages known interventional techniques. The treatment goal is to down-regulate the sympathetic activity in the pulmonary vascular tree to reduce vascular resistance and decrease pulmonary pressures. 'We're excited to be included in the TAP Pilot as the program will help streamline collaboration with FDA – from initiating our pivotal clinical study to accelerating access to this breakthrough therapy upon approval,' said Martin Grasse, Chief Executive Officer at Gradient Denervation Technologies. 'There are no approved drug or device therapies in the United States for this group of pulmonary hypertension patients, which reinforces the need to expedite access to new innovative therapies. We expect that guidance from TAP Pilot advisors will be immensely valuable in developing a targeted therapy intended to improve outcomes and quality of life for these underserved patients.' About Gradient Denervation TechnologiesGradient Denervation Technologies is a Paris-based medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension. Gradient leverages intellectual property developed at Stanford University. The Gradient Denervation System is for investigational use only and is not approved for commercial use. For more information, please visit: CONTACT: Media Contact contact@
Arabian Post
6 days ago
- Business
- Arabian Post
New Codeshare Horizons for Turkish Airlines and TAP Air Portugal
Arabian Post Staff -Dubai Turkish Airlines and TAP Air Portugal have deepened their codeshare collaboration, extending shared services to a host of new international destinations. Under the broadened agreement unveiled at the IATA Annual General Meeting on 4 June, travellers can now book seamless flights on routes to Brazil, Morocco, Qatar and Mauritius, while Turkish domestic holiday hotspots Dalaman and Bodrum are also integrated into the expanded arrangement. Bilal Ekşi, chief executive of Turkish Airlines, explained that the enhanced alliance 'offers greater flexibility and a wider range of travel options' and aims to bolster tourist and business connectivity between Türkiye and Portugal. TAP Air Portugal CEO Luís Rodrigues underscored that strategic partnerships are essential for extending the airline's reach eastwards, remarking that the arrangement 'provides our global passengers and our Portuguese community with increased options to visit new and exciting places using our Turkish Airlines partner'. ADVERTISEMENT Both carriers are members of the Star Alliance network, which encompasses more than 1,160 airports in over 190 countries. Turkish Airlines, holding a Guinness World Record since December 2024 for servicing the largest number of countries, flies to 340 destinations across 129 countries, while TAP Air Portugal ranks as Europe's safest airline and leads European service to Brazil. The update enhances booking convenience and connectivity for passengers. With the codeshare, flyers can book single-ticket itineraries that combine flights operated by each carrier, gain through-check of baggage, and accrue loyalty benefits across both their Miles&Smiles and TAP Miles&Go programmes. The inclusion of Brazil responds to TAP's strong presence in South America, where the airline operates over 1,250 weekly flights to 14 cities. Beyond South America, the new route options into North Africa, the Middle East, and the Indian Ocean signify a strategic push to diversify leisure and business travel offerings. Dalaman and Bodrum, already popular among European tourists, have now become a seamless gateway for Portuguese travellers to experience Turkish coastlines within the shared network. Theresa Walsh, aviation analyst at AeroInsight Strategies, noted that although codeshare agreements are common, this specific expansion stands out due to its geographical reach: 'Covering holiday-centric jets like Dalaman and bridging long-haul markets from Lisbon to São Paulo or Doha offers a genuinely integrated experience.' She projected that ticket sales could rise by up to 8–10% on the newly covered routes over the next year. Industry experts highlight that the move may also serve as a template for TAP as it navigates its planned partial privatisation. Portugal's government is preparing to offload its 51% stake in TAP, with a 49% stake open to bids from Air France‑KLM, Lufthansa or IAG. Strengthening international partnerships may enhance TAP's value proposition to prospective investors by showcasing expanded network synergy. Passenger advocacy groups have raised the question of whether such agreements might introduce pricing complexity, as combining two carriers can involve disparate fare rules. Both airlines have reassured the public that prices will remain transparent, with unified booking and support frameworks across shared routes. Operationally, the partners will synchronise schedules, optimise cabin connections, and co‑ordinate service protocols. TAP's fleet of Airbus NEO aircraft, lauded for fuel efficiency, will fly in conjunction with Turkish Airlines' diverse mix of modern jets. Premier travel agents in Lisbon and Istanbul report immediate upticks in enquiries. João Ribeiro, a senior agent at Lusitano Travel, commented: 'Our clients value simplicity. Booking Lisbon–Bodrum via Istanbul on one ticket, with aligned timings and baggage allowances, is exactly the evolution they want.' The alliance extension comes as both airlines seek to rebalance portfolios in response to shifting tourism trends and evolving geopolitics. Airlines across Europe are recalibrating their route maps to lean on partnership networks, minimising standalone risk. The expanded Turkish‑TAP codeshare is among the most notable examples of this trend in 2025.
Yahoo
11-06-2025
- Politics
- Yahoo
Israeli Defence Minister Katz asks Egypt to halt activists at border
Israeli Defence Minister Israel Katz called on Egypt on Wednesday to prevent activists from reaching Egypt's border with the Gaza Strip and entering the Palestinian territory. This would endanger the safety of Israeli troops in Gaza, which would not be allowed, Katz said in a statement. The Israeli army currently controls the Gaza side of the Rafah border crossing. Earlier Egyptian authorities called on activists to obtain official permits on their journey from Tunisia to the border with Gaza in solidarity with Palestinian civilians. Some 1,700 activists have set off from Tunis in buses and cars, according to the state news agency TAP, including around 200 from Algeria. They hope to travel through Libya and Egypt to reach the Rafah crossing with Gaza to protest Israel's conduct in the war. Among them were 52 French, 67 Algerian, 13 Moroccan and 8 Libyan nationals.
